Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...
It’s hard to believe it was almost 20 years ago when in 2005, Patrick Dempsey originated the role of Dr. Derek Shepherd in a ...
Third cohort dose is one million CAR positive cells; ten times higher than the first cohort dose . SAN JOSE, Calif., Nov. 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" ...
TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...
The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...
University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...
It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...
Kathy Bates has revealed why she decided against reconstruction surgery after her breast cancer diagnosis and mastectomy in ...
Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...